Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual trigger with GnRH agonist plus hCG versus hCG alone in IVF for women with diminished ovarian reserve
IRCT20160815029374N4Phase 3Completed
- Sponsor
- Vice chancellor of Mazandaran University of Medical Science.
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of gonadotropin-releasing hormone agonist and human chorionic gonadotropin in female infertility and Diminished Ovarian Reserve (DOR) (2 arms), sponsored by Vice chancellor of Mazandaran University of Medical Science. Primary endpoint: Pregnancy rate. Started May 2019; status: completed.
02
Drugs
gonadotropin-releasing hormone agonisthuman chorionic gonadotropin
03
Conditions
female infertilityDiminished Ovarian Reserve (DOR)
Beyond the preview
Go deeper on IRCT20160815029374N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160815029374N4.